The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Gender and liver fibrosis in chronic hepatitis: the role of iron status
Abstract
Summary: Background : The role of gender in the progression of fibrosis in chronic hepatitis C is still under investigation. Aim : To investigate whether gender affects the progression of liver disease and/or hides other risk factors. Methods : A prospective series of 121 consecutive patients with chronic hepatitis C underwent liver biopsy. Grading and staging for chronic hepatitis were each evaluated according to Ishak's classification. Results : In univariate and multivariate analysis on the whole group of patients, male gender was not associated either with significant liver fibrosis (Ishak's score >2) or with cirrhosis (Ishak's score >4). On the contrary, in univariate analysis on patients aged ≤50 years, male gender was nearly significantly (P = 0.06) predictive of liver fibrosis, whereas it was not in patients >50 years. Hepatic iron grading, along with age, was an independent factor associated with fibrosis. Moreover, the values of all the variables which describe iron status were significantly higher in males aged ≤50 years in comparison with females of the same age. Conclusions : In chronic hepatitis C, male gender may be predictive of liver fibrosis only in patients aged≤50 years. Among fibrogenetic factors hidden by gender, iron status could play a major role.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In alcoholic liver disease, both iron and alcohol contribute to the production of hepatic fibrosis.
“Specifically, in alcoholic liver disease, both iron and alcohol contribute to the production of hepatic fibrosis [1352-1358].”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1356]
Citations
Cites
Histological grading and staging of chronic hepatitis.
Ishak, K., Baptista, A., Bianchi, L., Callea, F., Groote, J. D., Gudat, F., Denk, H., Desmet, V., Korb, G., Macsween, R. N., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,290
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
A proposed system for the nomenclature of hepatitis C viral genotypes
Peter Simmonds, K., Alberti, A., Alter, H. J., Bonino, F., Bradley, D. W., Bréchot, C., Brouwer, J. T., Chan, S., Chayama, K., Chen, D., et al. (1994) · Hepatology · doi:10.1002/hep.1840190538 · Cited by 1,015
Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin
Kenny-Walsh, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401602 · Cited by 911
Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C
Liang, T. J., Rehermann, B., Seeff, L. B., & Hoofnagle, J. H. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00008 · Cited by 867
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c
Poynard, T., Ratziu, V., Charlotte, F., Goodman, Z., McHutchison, J., & Albrecht, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00097-0 · Cited by 749
Trevisani, F., D'Intino, P. E., Morselli‐Labate, A. M., Mazzella, G., Accogli, E., Caraceni, P., Domenicali, M., Notariis, S. D., Roda, E., & Bernardi, M. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00053-2 · Cited by 732
Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay
Stuyver, L. J., Rossau, R., Wyseur, A., Duhamel, M., Vanderborght, B., HEUVERSWYN, H. V., & Maertens, G. G. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-6-1093 · Cited by 679
The Long–Term Pathological Evolution of Chronic Hepatitis C
Yano, M., Kumada, H., Kage, M., Ikeda, K., Shimamatsu, K., INOUE, O., Hashimoto, E., Lefkowitch, J. H., Ludwig, J., & Okuda, K. (1996) · Hepatology · doi:10.1002/hep.510230607 · Cited by 597
Parola, M., Pinzani, M., Casini, A., Albano, E., Poli, G., Gentilini, A., Geñtilini, P., & Mu, D. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1927 · Cited by 330
Iron and Chronic Viral Hepatitis
Bonkovsky, H. L., Banner, B. F., & Rothman, A. L. (1997) · Hepatology · doi:10.1002/hep.510250345 · Cited by 329
Angelucci, E., Muretto, P., Nicolucci, A., BARONCIANI, D., Erer, B., Gaziev, J., Ripalti, M., Sodani, P., Tomassoni, S., Visani, G., et al. (2002) · Blood · doi:10.1182/blood.v100.1.17 · Cited by 309
Roudot‐Thoraval, F., Bastie, A., Pawlotsky, J., & Dhumeaux, D. (1997) · Hepatology · doi:10.1002/hep.510260233 · Cited by 293
Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats
Yasuda, M., Shimizu, I., Shiba, M., & Ito, S. (1999) · Hepatology · doi:10.1002/hep.510290307 · Cited by 283
Martino, V. D., Lebray, P., Myers, R. P., Pannier, E., Paradis, V., Charlotte, F., Moussalli, J., Thabut, D., Buffet, C., & Poynard, T. (2004) · Hepatology · doi:10.1002/hep.20463 · Cited by 280
Natural history of hepatitis C
Seeff, L. B. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00374-5 · Cited by 240
Hayashi, H., Takikawa, T., Nishimura, N., Yano, M., Isomura, T., & Sakamoto, N. (1994) · PubMed · Cited by 226
Fontana, R. J., Israel, J., LeClair, P., Banner, B. F., Tortorelli, K., Grace, N. D., Levine, R. A., Fiarman, G. S., Thiim, M., Tavill, A. S., et al. (2000) · Hepatology · doi:10.1002/hep.510310325 · Cited by 165
Hepatitis C, iron status, and disease severity: Relationship with HFE mutations
Tung, B. Y., Emond, M. J., Bronner, M. P., Raaka, S. D., Cotler, S. J., & Kowdley, K. V. (2003) · Gastroenterology · doi:10.1053/gast.2003.50046 · Cited by 154
Thorburn, D., Curry, G., Spooner, R., Spence, E., Oien, K. A., Halls, D. J., Fox, R., McCruden, E. A. B., MacSween, R. N. M., & Mills, P. R. (2002) · Gut · doi:10.1136/gut.50.2.248 · Cited by 133
Inhibitory effect of oestradiol on activation of rat hepatic stellate cells in vivo and in vitro
Shimizu, I., Mizobuchi, Y., Yasuda, M., Shiba, M., Ma, Y.-R., HORIE, T., Liu, F., & Ito, S. (1999) · Gut · doi:10.1136/gut.44.1.127 · Cited by 120
Czaja, A. J., Carpenter, H. A., Santrach, P. J., & Moore, S. B. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80186-3 · Cited by 116
Natural history of chronic hepatitis C.
Pagliaro, L., Peri, V., Linea, C., Cammà, C., Giunta, M., & Magrin, S. (1999) · PubMed · Cited by 107
Fong, T., Han, S. H., Tsai, N. C. S., Morgan, T. R. M., Mizokami, M., QianP, D., Phan, C., Goad, K., & Redeker, A. G. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80308-5 · Cited by 95
Gardi, C., Arezzini, B., Fortino, V., & Comporti, M. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01257-1 · Cited by 94
Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C
Beinker, N. K., Voigt, M. D., Arendse, M., Smit, J. L., Stander, I. A., & Kirsch, R. E. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80231-5 · Cited by 93
Determinants of age at menopause in Italy: results from a large cross-sectional study
Meschìa, M., Pansini, F. S., Modena, A. B., Aloysio, D. D., Gambacciani, M., Parazzini, F., Campagnoli, C., Maiocchi, G., & Peruzzi, E. (2000) · Maturitas · doi:10.1016/s0378-5122(99)00095-x · Cited by 92
Effects of Iron Loading on Pathogenicity in Hepatitis C Virus-Infected Chimpanzees
Bassett, S. E., Bisceglie, A. M. D., Bacon, B. R., Sharp, R. M., Govindarajan, S., Hubbard, G. B., Brasky, K. M., & Lanford, R. E. (1999) · Hepatology · doi:10.1002/hep.510290623 · Cited by 87
Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C.
Ikura, Y., Morimoto, H., Johmura, H., Fukui, M., & Sakurai, M. (1996) · PubMed · Cited by 85
Approach to the Patient with Chronic Hepatitis C Virus Infection
Herrine, S. K. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-10-200205210-00010 · Cited by 62
Hispathology of chronic hepatitis C in relation to epidemiological factors
Delladetsima, J. K., Rassidakis, G. Z., Tassoppoulos, N. C., Papatheodoridis, G., Smyrnoff, T., & Vafiadis, I. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80182-6 · Cited by 60
Tsai, N., Zuckerman, E., Han, S. H., Goad, K., Redeker, A. G., & Fong, T. (1997) · PubMed · Cited by 56
Higher elimination rate of hepatitis C virus among women
Yamakawa, Y., Sata, M., Suzuki, H., Noguchi, S., & Tanikawa, K. (1996) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.1996.tb00104.x · Cited by 55
Kaji, K., Nakanuma, Y., Sasaki, M., Unoura, M., KOBAYASHI, K. P., & Nonomura, A. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90269-4 · Cited by 38
Chronic hepatitis C treated with phlebotomy alone: biochemical and histological outcome
Sartori, M. (2001) · Digestive and Liver Disease · doi:10.1016/s1590-8658(01)80072-4 · Cited by 32
Self-citationDietary iron restriction improves aminotransferase levels in chronic hepatitis C patients.
Iwasa, M., Kaito, M., Ikoma, J., Kobayashi, Y., Tanaka, Y., Higuchi, K., Takeuchi, K., Iwata, K., Watanabe, S., & Adachi, Y. (2002) · PubMed · Cited by 32
Kleckner, M. S., Baggenstoss, A. H., & Weir, J. F. (1955) · American Journal of Clinical Pathology · doi:10.1093/ajcp/25.8.915 · Cited by 31
Factors associated with severity and disease progression in chronic hepatitis C.
Tassopoulos, N., Papatheodoridis, G., Katsoulidou, A., Delladetsima, J. K., Sypsa, V., Touloumi, G., Nikandros, M., & Hatzakis, A. (1998) · PubMed · Cited by 25
Iron in hepatitis C: villain or innocent bystander?
Ioannou, G. N., Tung, B. Y., & Kowdley, K. V. (2002) · PubMed · Cited by 25
Chronic hepatitis C is mild in menstruating women
Sartori, M., Andorno, S., Rigamonti, C., Grossini, E., Nicosia, G., & Boldorini, R. L. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02368.x · Cited by 24
Self-citationEvaluation of iron status in patients with chronic hepatitis C.
Sartori, M., Andorno, S., Terra, G. L., Boldorini, R. L., Leone, F., Pittau, S., Zecchina, G., Aglietta, M., & Saglio, G. N. (1998) · PubMed · Cited by 21
Self-citationAlcohol Consumption and Non-Cirrhotic Chronic Hepatitis: A Case-Control Study
Corrao, G., Aricò, S., RUSSO, R., Carle, F., GALATOLA, G., TORCHIO, P., Moiraghi, A. R., di Orio, F., & PIERRE, M. D. L. (1991) · International Journal of Epidemiology · doi:10.1093/ije/20.4.1037 · Cited by 19
The influence of host factors on the natural history of chronic hepatitis C viral infections
Minuk, G. Y. (1999) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1999.00158.x · Cited by 14
Epidemiological risk factors and clinico-pathological presentation in chronic hepatitis C.
Iacono, O. L., Decastro, M., Garcı́a-Buey, L., García‐Monzón, C., Borque, M. J., Sanz, P., Garcia-Sanchez, A., & Moreno‐Otero, R. (1998) · PubMed · Cited by 6
The advantage of gastrectomized patients in management of their chronic hepatitis C.
Hayashi, H., Takikawa, T., Arai, N., & Yano, M. (1997) · PubMed · doi:10.18999/nagjms.60.3-4.119 · Cited by 3
Flagged first, then by citations
Research works printed but not linked: 3
- Muller R., 1996, The natural history of hepatitis C: clinical experiences, J Hepatol, 24, 52
- Searle JW, 1987, Pathology of the Liver
- Sartori M, 2001, Gender and liver fibrosis in chronic hepatitis C, Hepatology, 34, 570A
Cited by
Sorted by citations
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
Influence of sex differences on microRNA gene regulation in disease
Sharma, S., & Eghbali, M. (2014) · Biology of Sex Differences · doi:10.1186/2042-6410-5-3 · Cited by 204
Gender differences in Wilson's disease
Litwin, T., Gromadzka, G., & Członkowska, A. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.08.028 · Cited by 155
Shimizu, I. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i32.4295 · Cited by 145
Gender-related variations in iron metabolism and liver diseases
Harrison-Findik, D. D. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i8.302 · Cited by 103
Czaja, A. J. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15173 · Cited by 47
Khairy, M., ABDEL-RAHMAN, M. D. H. N. A. H. A. M. A. A., Raziky, M. E., Elakel, W., Zayed, N. A., Khatab, H., & Esmat, G. (2012) · Hepatitis Monthly · doi:10.5812/hepatmon.6718 · Cited by 42
Serum iron parameters in cirrhosis and chronic hepatitis: Detailed description
Büyükaşık, N. Ş., Nadir, İ., Akın, F. E., Çakal, B., Kav, T., Ersoy, O., & Büyükaşık, Y. (2011) · The Turkish Journal of Gastroenterology · doi:10.4318/tjg.2011.0323 · Cited by 31
Tan, L., Zhou, Q., Liu, J., Liu, Z., & Shi, R. (2023) · Food & Function · doi:10.1039/d2fo04082d · Cited by 28
Al-Khabori, M. K., Daar, S., Al‐Busafi, S. A., Al-Dhuhli, H., Alumairi, A. A., Hassan, M., Rahbi, S. A., & Ajmi, U. A. (2018) · Hematology · doi:10.1080/10245332.2018.1540518 · Cited by 23
Role of gender and age in features of Wilson’s disease
Cai, L., Huang, X., Ye, Y., Yang, D., Xie, L., Fu, D., Peng, L., Zhou, D., & Liao, J. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1176946 · Cited by 18
Xu, Z., He, B., Jiang, Y., Zhang, M., Tian, Y., Zhou, N., Zhou, Y., Chen, M., Tang, M., Gao, J., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108987 · Cited by 17
Li, X., Feng, Z., Tang, W., Yu, X., Qian, Y., Liu, B., Li, X., Yang, R., & Yu, Y. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01429 · Cited by 16
Predisposing factors for advanced liver fibrosis in patients with sickle cell disease
Manganas, K., Delicou, S., Xydaki, A., Kourakli, A., Evliati, L., Vlachaki, E., Klironomos, E., Diamantidis, M. D., Lafiatis, I., Kattamis, A. C., et al. (2023) · British Journal of Haematology · doi:10.1111/bjh.18970 · Cited by 13
Choroba Wilsona – czynniki wpływające na obraz kliniczny
Litwin, T., & Członkowska, A. (2013) · Neurologia i Neurochirurgia Polska · doi:10.5114/ninp.2013.34397 · Cited by 12
Belci, P., Collo, A., Martorana, M. C., Evangelista, A., Giunti, S., Gambino, R., Cassader, M., Bo, S., & Durazzo, M. (2016) · Hepatoma Research · doi:10.20517/2394-5079.2015.53 · Cited by 10
Gromadzka, G., Wierzbicka, D., Litwin, T., & Przybyłkowski, A. M. (2020) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2020.126637 · Cited by 9
Mysko, C., Landi, S., Purssell, H., Allen, A. J., Prince, M., Lindsay, G., Rodrigues, S., Irvine, J., Street, O., Gahloth, D., et al. (2025) · BJC Reports · doi:10.1038/s44276-025-00126-5 · Cited by 6
Chronic hepatitis C: hepatic iron content does not correlate with response to antiviral therapy
Pereira, P. D. S. F., Silva, I. S. D. S. E., Uehara, S. N. D. O., Emori, C. T., Lanzoni, V. P., Silva, A. E. B., & Ferraz, M. L. G. (2009) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652009000600004 · Cited by 6
John, T. M. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00021-9 · Cited by 4
Banwell, C. L., Dance, P., Olsen, A., & Dixon, J. (2009) · ANU Open Research (Australian National University) · Cited by 3
Büyükaşık, N. Ş., & Büyükaşık, Y. (2016) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1508-107 · Cited by 3
John, T. M. S. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-2954-0.50027-2 · Cited by 3
Analysis of determinant factors of liver fibrosis progression in ex-thalassemic patients
Rostami, T., Monzavi, S. M., Poustchi, H., Khoshdel, A., Behfar, M., & Hamidieh, A. A. (2020) · International Journal of Hematology · doi:10.1007/s12185-020-02998-4 · Cited by 2
Wilson's disease - clinical picture, factors influencing disease progression, treatment methods
Korga, M., Pawlik, P., Zaroda, P., Wawrzkowicz, J., Niewinna, P., Dąda, P., Mańdziuk, D., Żuchowski, M., Kołodziej, K., & Kołodziej, W. (2024) · Quality in Sport · doi:10.12775/qs.2024.15.51826 · Cited by 2
John, T. M. S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00019-4 · Cited by 1
Predictors of Liver Fibrosis in Patients with Chronic HCV Infection
Ceylan, B., Yardımcı, A. C., Fıncancı, M., Tözalgan, Ü., Eren, G., MÜDERRİSOĞLU, C., & İnci, A. (2012) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2011-25802 · Cited by 1
O papel das mutações do gene HFE e da sobrecarga de ferro na evolução da hepatite crônica pelo VHC
da Silva, A. L. B. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2009.tde-08122009-181724
Particularidades del carcinoma hepatocelular en los pacientes con cirrosis hepática
Originales, T., Ivón, M., Fernández, C., Yaritza, I., Díaz, L., del Vallín, S. L., & Hernández, G. (2011) · DOAJ (DOAJ: Directory of Open Access Journals)
John, T. M. S. (2009) · Elsevier eBooks · doi:10.1016/b978-84-458-1911-1.50023-3
Awadh, A. A. (2018) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3154f431
Кузнецова, А. С., Dolgushina, A. I., Kudrinskaya, Y. I., Selyanina, A. A., Khusainova, G. M., & Genkel, V. V. (2023) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-206-10-43-49
Чернодробни усложнения при ß-таласемия
Кофинова, Д. (2023) · Редки болести и лекарства сираци · doi:10.36865/2023.v14i1.172
Metadata
- Authors
- Rigamonti, C., Andorno, S., Maduli, E., Capelli, F., Boldorini, R., & Sartori, M.
- Affiliations
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- Corresponding author
- Sartori, M.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2005-06
- Volume
- 21
- Issue
- 12
- Pages
- 1445-1451
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2045385622
- Cited by
- 34
- References
- 45
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 5 · 2022: 1 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 1 · 2016: 2 · 2014: 1 · 2013: 1 · 2012: 3
- FWCI
- 0.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Alimentary Pharmacology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- chronic hepatitis C, liver fibrosis, gender differences, iron status, liver cirrhosis, Ishak score, fibrosis progression, age as risk factor
- MeSH terms
- Adult, Aged, Biopsy, Female, Ferritins, Humans, Iron, Liver Cirrhosis, Male, Middle Aged, Prospective Studies, Transferrin, Disease Progression, Hepatitis C, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review